Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

Epoxide Syntheses and Ring-Opening Reactions in Drug Development
Fotini Moschona, Ioanna Savvopoulou, Μαρία Τσιτοπούλου, et al.
Catalysts (2020) Vol. 10, Iss. 10, pp. 1117-1117
Open Access | Times Cited: 95
Metabolic roles of G protein‐coupled receptor signaling in obesity and type 2 diabetes
Luiz F. Barella, Shanu Jain, Takefumi Kimura, et al.
FEBS Journal (2021) Vol. 288, Iss. 8, pp. 2622-2644
Open Access | Times Cited: 41
Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile
Yuval Cohen, Andrew Kolodziej, Marshall Morningstar
Obesity (2024) Vol. 32, Iss. 7, pp. 1235-1244
Open Access | Times Cited: 5
Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System
Ana Lago-Fernandez, Sara Zarzo-Arias, Nadine Jagerovic, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1001-1001
Open Access | Times Cited: 36
The interplay of leptin and the peripheral endocannabinoid system in energy homeostasis and obesity; modulation by linoleic acid and exercise
Quratul Ain, Melpomeni Malamouli, Deanne H. Hryciw
Advanced Exercise and Health Science (2025)
Open Access
The endocannabinoid system is modulated in reward and homeostatic brain regions following diet-induced obesity in rats: a cluster analysis approach
Romain Bourdy, Alexandra Hertz, Dominique Filliol, et al.
European Journal of Nutrition (2021) Vol. 60, Iss. 8, pp. 4621-4633
Open Access | Times Cited: 26
Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System—Implications for Health and Disease
Estefanía Moreno, Milena Čavić, Enric I. Canela
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3661-3661
Open Access | Times Cited: 21
Pharmacotherapy in Childhood Obesity
Peter Kühnen, Heike Biebermann, Susanna Wiegand
Hormone Research in Paediatrics (2021) Vol. 95, Iss. 2, pp. 177-192
Open Access | Times Cited: 21
Identifying FAAH Inhibitors as New Therapeutic Options for the Treatment of Chronic Pain through Drug Repurposing
Anca Zanfirescu, Georgiana Nițulescu, Dragoș Paul Mihai, et al.
Pharmaceuticals (2021) Vol. 15, Iss. 1, pp. 38-38
Open Access | Times Cited: 20
Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
Justin Matheson, Xin Ming M Zhou, Zoe Bourgault, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1316-1316
Open Access | Times Cited: 20
Obesity as a Condition Determined by Food Addiction: Should Brain Endocannabinoid System Alterations Be the Cause and Its Modulation the Solution?
Marialuisa de Ceglia, Juan Decara, Silvana Gaetani, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1002-1002
Open Access | Times Cited: 19
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia
Tibor Štark, Fabio Arturo Iannotti, Serena Di Martino, et al.
Biomolecules (2022) Vol. 12, Iss. 1, pp. 108-108
Open Access | Times Cited: 12
Cannabinoid receptors distribution in mouse cortical plasma membrane compartments
Hajar Miranzadeh Mahabadi, Haseeb Bhatti, Robert B. Laprairie, et al.
Molecular Brain (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB1R) “Cis-On” Agonist
Diego A. Rodríguez‐Soacha, Sophie A. M. Steinmüller, Ali Işbilir, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 16, pp. 2410-2435
Open Access | Times Cited: 11
Targeting the endocannabinoid system in diabesity: Fact or fiction?
Farah Deeba, Ashish Kumar, Monalisa Mukherjee, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 7, pp. 1750-1758
Closed Access | Times Cited: 14
Turning the clock forward: New pharmacological and non pharmacological targets for the treatment of obesity
Anna Ferrulli, Ileana Terruzzi, Pamela Senesi, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 6, pp. 1320-1334
Closed Access | Times Cited: 10
Integration of Endogenous Opioid System Research in the Interprofessional Diagnosis and Treatment of Obesity and Eating Disorders
Marcela Rodríguez-Flores, Sylvana Stephano Zuñiga
Advances in neurobiology (2024), pp. 357-380
Closed Access | Times Cited: 1
Associations of cannabis use and body mass index–The Coronary Artery Risk Development in Young Adults (CARDIA) study
Julian Jakob, Fiona Schwerdtel, Stephen Sidney, et al.
European Journal of Internal Medicine (2024) Vol. 129, pp. 41-47
Open Access | Times Cited: 1
Brain endocannabinoid control of metabolic and non-metabolic feeding behaviors
Min Zhang, Qingyu Wang, Ying Wang
Neurochemistry International (2024) Vol. 183, pp. 105921-105921
Closed Access | Times Cited: 1
Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity
Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela Carmen Ababei, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1667-1667
Open Access | Times Cited: 4
Novel cannabinoid receptor 1 inverse agonist CRB‐913 enhances efficacy of tirzepatide, semaglutide, and liraglutidein the diet‐induced obesity mouse model
Marshall Morningstar, Andrew Kolodziej, Suzie A. Ferreira, et al.
Obesity (2023) Vol. 31, Iss. 11, pp. 2676-2688
Open Access | Times Cited: 4
New paradigms for the treatment of lysosomal storage diseases: targeting the endocannabinoid system as a therapeutic strategy
Edward H. Schuchman, María Dolores Ledesma, Calogera M. Simonaro
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 9
CB1 Ligand AM251 Induces Weight Loss and Fat Reduction in Addition to Increased Systemic Inflammation in Diet-Induced Obesity
Lannie O’Keefe, Teresa Vu, Anna Simcocks, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11447-11447
Open Access | Times Cited: 4
Caloric restriction, physical exercise, and CB1 receptor blockade as an efficient combined strategy for bodyweight control and cardiometabolic status improvement in male rats
Luisa M. Lopez Trinidad, Rosario Martínez, Garyfallia Kapravelou, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Weight Loss and Therapeutic Metabolic Effects of Tetrahydrocannabivarin (THCV)-Infused Mucoadhesive Strips
Gregory L. Smith
Cannabis (2024)
Open Access
Page 1 - Next Page

Scroll to top